Click to copy
Click to copy

Bellicum Pharmaceuticals: 2Q Earnings Snapshot

August 5, 2019

HOUSTON (AP) _ Bellicum Pharmacueticals Inc. (BLCM) on Monday reported a loss of $26.9 million in its second quarter.

The Houston-based company said it had a loss of 58 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.

The drug developer posted revenue of $1.4 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $233,000.

In the final minutes of trading on Monday, the company’s shares hit $1.30. A year ago, they were trading at $5.87.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLCM at https://www.zacks.com/ap/BLCM

All contents © copyright 2019 The Associated Press. All rights reserved.